Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-06-12
2009-12-15
Krass, Frederick (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C424S400000
Reexamination Certificate
active
07632853
ABSTRACT:
The present invention describes a soluble stable pharmaceutical composition for the administration of HIV protease inhibitors. More specifically the composition comprises a solution of an HIV protease inhibitor in a combination of suitable pharmaceutical organic solvents, a surfactant and a bioavailability enhancer. It is also described a process for the obtainment of concentrated pharmaceutical compositions used in the administration of HIV protease inhibitors compounds. The composition of the present invention is suitable for the preparation of oral solutions for the administration of active drugs and for the encapsulation in hard gelatin capsules or soft gelatin capsules.
REFERENCES:
patent: 6008228 (1999-12-01), Bailey et al.
patent: 6232333 (2001-05-01), Lipari et al.
patent: WO-96/39142 (1996-12-01), None
patent: WO 98/57648 (1998-12-01), None
Rowe et al., Handbook of Pharmaceutical Excipients, 2006, Pharmaceutical Press, Fifth Edition, pp. 545-550 (Polyethylene Glycol).
Wikipedia, http://en.wikipedia.org/wiki/Vacuum-distillation, pp. 1-2.
Wikipedia, http://en.wikipedia.org/wiki/Distillation, pp. 1-11.
CU Boulder Organic Chemistry Undergrauate Courses, Lab Techniques, http://we.archive.or/web/20010419135852/orgchem.colorado.edu/handbksupport/dist/dist.html, pp. 1-2.
CUBoulder Organic Chemistry Undergraduate Courses, Lab Techniques, http: //web.archive.org/web/20020417050311/orgchem.colorado.edu/hndbksupport/solvremoval/solvremoval.html, pp. 1-4.
L. Eldred, The Hopkins HIV Report, “Adherence in the Era of Protease Inhibitors”, 1997.
F.M. Hecht et al., Abstract of Presentation from the 5th Conference on Retroviruses and Opportunistic Infections, Feb. 1-5, 1998, Chicago, IL.
M. Chesney et al., “Adherence to Combination Therapy in AIDS Clinical Trials (1997)”, presented at the Annual Meeting of the AIDS Clinical Trials Group, Jul. 1997, Washington, D.C.
J. Walsh et al., Abstract of presentation “Adherence to proteinase inhibitor based highly effective antiretroviral therapy (HEART)” from 12th International AIDS Conference held in Geneva, Switzerland, Jun. 28-Jul. 3, 1998.
Pacheco Ogari
Rusoo Elisa
Russo Valter
Birch & Stewart Kolasch & Birch, LLP
Cristalia Produtos Quimicos Farmaceuticos LTDA
Huang Gigi
Krass Frederick
LandOfFree
Soluble, stable and concentrated pharmaceutical composition... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble, stable and concentrated pharmaceutical composition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble, stable and concentrated pharmaceutical composition... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4138915